| Phase 14 trials |
|
Phase 1
|
NCT00098995 |
Dec 2004 → Jan 2010 |
cervical cancer |
Peter MacCallum Cancer Centre, Australia |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00033410 |
Mar 2002 → ? |
lung cancer |
California Cancer Consortium |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00005078 |
Mar 2000 → Jul 2012 |
cancer of unknown primary site |
City of Hope Medical Center |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00003288 |
Aug 1998 → Jun 2003 |
childhood malignant neoplasm |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
| Phase 1/22 trials |
|
Phase 1/2
|
NCT06848556 |
May 2021 → Nov 2023 |
hepatocellular carcinoma |
Zhejiang Raygene Pharmaceuticals Co., Ltd |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT02174549 |
Sep 2014 → Mar 2028 expected |
hepatocellular carcinoma, neuroendocrine neoplasm |
Teclison Ltd. |
Recruiting
|
No outcome recorded
|
| Phase 28 trials |
|
Phase 2
|
NCT04701476 |
May 2021 → Mar 2027 expected |
colorectal cancer |
Teclison Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT03145558 |
Dec 2017 → Jun 2024 |
hepatocellular carcinoma |
Teclison Ltd. |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT03259867 |
Jul 2017 → Dec 2026 expected |
gastric cancer, hepatocellular carcinoma |
Teclison Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT00066742 |
Sep 2003 → Aug 2009 |
small cell lung carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00025363 |
Nov 2001 → Oct 2007 |
alveolar rhabdomyosarcoma, childhood botryoid rhabdomyosarcoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00020696 |
Jun 2001 → Apr 2006 |
ovarian carcinoma, peritoneal carcinoma |
Gynecologic Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00003369 |
Aug 1998 → Oct 2003 |
cervical cancer |
SWOG Cancer Research Network |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00002774 |
Jun 1996 → Jun 2000 |
head and neck squamous cell carcinoma |
Stanford University |
Completed
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT06844357 |
Mar 2025 → Apr 2029 expected |
hepatocellular carcinoma |
Zhejiang Raygene Pharmaceuticals Co., Ltd |
Recruiting
|
No outcome recorded
|
| Phase 35 trials |
|
Phase 3
|
NCT00262821 |
Feb 2006 → Aug 2010 |
cervical adenosquamous carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 3
|
NCT00174837 |
Apr 2005 → Jan 2008 |
head and neck squamous cell carcinoma |
Sanofi |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00094081 |
Oct 2002 → Sep 2006 |
head and neck neoplasm |
Sanofi |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00006484 |
Nov 2000 → Apr 2006 |
lung cancer |
SWOG Cancer Research Network |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00017459 |
Jul 2000 → Feb 2004 |
lung cancer |
Sanofi |
Completed
|
No outcome recorded
|